Top 10 CRO Services Provider 2026
The Intelligence Behind Clinical Discovery
A promising healthcare idea is only the beginning. Before a new treatment can reach the people who need it, it must move through years of research, clinical trials, data analysis, and regulatory review. Every stage brings its own challenges, and CROs are helping life sciences companies navigate this complex journey with greater expertise and structure.
At Healthcare Business Outlook, we see CRO services as much more than operational support. They bring together scientific knowledge, clinical expertise, technology, and specialized capabilities to help research programs move forward. From clinical trial management and patient recruitment to data management and regulatory support, CROs are becoming valuable partners throughout the development process.
The landscape is evolving rapidly. Artificial intelligence, real-world data, advanced analytics, and decentralized trials are introducing new ways to design and manage clinical research. Yet, even as technology opens new possibilities, the fundamentals remain unchanged: reliable evidence, careful execution, regulatory compliance, and a strong focus on quality and patients.
In this edition, we look at the organizations, expertise, and ideas influencing the evolving CRO landscape. We explore how these partners are helping sponsors navigate complexity while creating more efficient and thoughtful approaches to research.
As you turn the pages, look beyond the familiar headlines of trials and treatments. Discover the people, ideas, technologies, and partnerships working behind the scenes, uncovering new possibilities and changing how healthcare research moves forward.
Company:
Altasciences
Management:
Marie-Hélène Raigneau
Designation:
CEO
Headquarters:
Laval, QC
Website:
altasciences.com
Altasciences is a mid-sized contract research organization supporting biopharmaceutical companies across the drug development journey. Its services span preclinical safety testing, clinical pharmacology, bioanalysis, research support, manufacturing, and analytical services, helping clients advance drug candidates from early development through clinical stages with scientific expertise, flexible solutions, and a focus on efficient, compliant outcomes.
Company:
Bright Research
Management:
Andrea Fenton Abbs
Designation:
CEO and Founder
Headquarters:
Minneapolis,MI
Website:
brightresearch.com
Bright Research is a clinical research organization specializing in medical device clinical trials. The company supports studies from concept to completion, offering clinical strategy, regulatory consultation, site management, data management, monitoring, safety management, and statistical services. With a focus on personalized service, innovative strategies, and quality execution, Bright Research helps medical device companies navigate complex clinical research requirements.
Company:
Charles River Laboratories
Management:
Birgit Girshick
Designation:
CEO
Headquarters:
Wilmington, MA
Website:
criver.com
Charles River Laboratories is a global research and drug development partner supporting pharmaceutical and biotechnology organizations across the drug development lifecycle. Its capabilities span research models, discovery, preclinical testing, clinical development, laboratory services, manufacturing, and regulatory support, helping clients accelerate the development and safe manufacture of new therapies.
Company:
Eurofins
Management:
Dr. Gilles Martin
Designation:
CEO
Headquarters:
Luxembourg, LU
Website:
eurofins.com
Eurofins Scientific is a global life sciences company providing laboratory testing, research, and analytical services across pharmaceutical, food, environmental, and consumer industries. Its capabilities include BioPharma services, genomics, clinical diagnostics, discovery pharmacology, and contract research, supported by a broad international laboratory network and extensive analytical expertise.
Company:
Evotec
Management:
Dr. Christian Wojczewsk
Designation:
CEO
Headquarters:
Princeton, NJ
Website:
evotec.com
Evotec is a global life sciences and drug discovery company that partners with pharmaceutical and biotechnology organizations to advance the development of new therapies. Its capabilities span early-stage drug discovery, preclinical research, clinical development, and technology-driven platforms, combining scientific expertise, data, and innovation to accelerate the delivery of potential treatments.
Company:
Medpace
Management:
August Troendle
Designation:
CEO & President
Headquarters:
Cincinnati, OH
Website:
medpace.com
Medpace is a global contract research organization (CRO) providing comprehensive clinical development services to pharmaceutical, biotechnology, and medical device companies. Its capabilities span clinical research, regulatory services, laboratory services, data management, biostatistics, and pharmacovigilance, helping clients advance innovative therapies efficiently from early development through commercialization.
Company:
Parexel
Management:
Sheri McCoy
Designation:
CEO
Headquarters:
Raleigh, North Carolina
Website:
parexel.com
Parexel is a global clinical research organization (CRO) providing comprehensive clinical development and consulting services to pharmaceutical, biotechnology, and life sciences companies. Its capabilities span clinical trials, regulatory strategy, real-world evidence, market access, pharmacovigilance, and medical communications, helping clients advance innovative therapies efficiently while keeping patient needs, data integrity, and regulatory requirements at the center.
Company:
QPS Holdings
Management:
Dr. Benjamin Chien
Designation:
CEO
Headquarters:
Newark, DE
Website:
qps.com
QPS is a global contract research organization (CRO) providing drug discovery, preclinical, and clinical research services to pharmaceutical and biotechnology companies. Its capabilities span bioanalysis, pharmacology, toxicology, clinical research, and drug development, helping clients advance innovative therapies through flexible, science-driven solutions and integrated research expertise across multiple stages of development.
Company:
Solvias AG
Management:
Danny Galbraith
Designation:
Chief Scientific Officer
Headquarters:
Morrisville, NC
Website:
solvias.com
Solvias is the leading global contract research organization (CRO) and analytical testing partner specializing in quality control, regulatory compliance, and laboratory services for the pharmaceutical, biotechnology, and life sciences industries. Originating in Switzerland as a Ceiba-Geigy spin-off, the company supports the development of small molecules, biologics, vaccines, gene and cell therapies with advanced analytical expertise, helping clients accelerate innovation while ensuring every therapy meets the highest standards of quality, safety, and compliance.
Company:
Worldwide Clinical Trials
Management:
Alistair Macdonald
Designation:
CEO
Headquarters:
Research Triangle Park, NC
Website:
worldwide.com
Worldwide Clinical Trials is a global contract research organization (CRO) that supports pharmaceutical and biotechnology companies throughout the drug development lifecycle. Its services span clinical research, bioanalytical services, clinical pharmacology, real-world evidence, and late-phase studies. With expertise across areas including oncology, neuroscience, rare disease, and cardiovascular and metabolic conditions, Worldwide delivers tailored solutions to advance new therapies.